Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bitoun

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|April 24, 2013
Role of dynamin 2 in the disassembly of focal adhesionsLaura Briñas, Stéphane Vassilopoulos, Gisèle Bonne, et al.
Molecular Therapy. Nucleic Acids|September 14, 2016
Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicingDelphine Trochet, Bernard Prudhon, Arnaud Jollet, et al.
Cell Communication and Signaling : CCS|October 22, 2025
Lamin A/C protects chromatin accessibility during mechanical loading in human skeletal muscleSaline Jabre, Emeline Cherchame, Natalia Pinzón, et al.
Scientific Reports|February 9, 2019
Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse modelAnaïs Fongy, Sestina Falcone, Jeanne Lainé, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 7, 2002
The HERV-W/7q family in the human genome. Potential for protein expression and gene regulationPatrick M Alliel, Jean-Pierre Périn, Danièle Goudou, et al.
American Journal of Human Genetics|September 19, 2025
Allele-specific RNAi therapy corrects an extracellular matrix defect in Schuurs-Hoeijmakers syndromeLylia Mekzine, Natalia Pinzón, Kamel Mamchaoui, et al.
Neuromuscular Disorders : NMD|April 9, 2008
A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findingsMarc Bitoun, Tanya Stojkovic, Bernard Prudhon, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutationsSwati Dudhal, Lylia Mekzine, Bernard Prudhon, et al.
Muscle & Nerve|December 25, 2003
Neuromuscular expression of the BTB/POZ and zinc finger protein myoneurinCarmen Cifuentes-Diaz, Marc Bitoun, Daniele Goudou, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathyDelphine Trochet, Bernard Prudhon, Lylia Mekzine, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Molecular Medicine (Berlin, Germany)|April 24, 2013
Role of dynamin 2 in the disassembly of focal adhesionsLaura Briñas, Stéphane Vassilopoulos, Gisèle Bonne, et al.
Molecular Therapy. Nucleic Acids|September 14, 2016
Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicingDelphine Trochet, Bernard Prudhon, Arnaud Jollet, et al.
Cell Communication and Signaling : CCS|October 22, 2025
Lamin A/C protects chromatin accessibility during mechanical loading in human skeletal muscleSaline Jabre, Emeline Cherchame, Natalia Pinzón, et al.
Scientific Reports|February 9, 2019
Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse modelAnaïs Fongy, Sestina Falcone, Jeanne Lainé, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 7, 2002
The HERV-W/7q family in the human genome. Potential for protein expression and gene regulationPatrick M Alliel, Jean-Pierre Périn, Danièle Goudou, et al.
American Journal of Human Genetics|September 19, 2025
Allele-specific RNAi therapy corrects an extracellular matrix defect in Schuurs-Hoeijmakers syndromeLylia Mekzine, Natalia Pinzón, Kamel Mamchaoui, et al.
Neuromuscular Disorders : NMD|April 9, 2008
A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findingsMarc Bitoun, Tanya Stojkovic, Bernard Prudhon, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutationsSwati Dudhal, Lylia Mekzine, Bernard Prudhon, et al.
Muscle & Nerve|December 25, 2003
Neuromuscular expression of the BTB/POZ and zinc finger protein myoneurinCarmen Cifuentes-Diaz, Marc Bitoun, Daniele Goudou, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathyDelphine Trochet, Bernard Prudhon, Lylia Mekzine, et al.
Pageof 6